Prospective cohort study of pediatric acute lymphoblastic leukemia patients treated with Tokyo Children's Cancer Study Group risk stratification TCCSG ALL L09-1603.version1.1
Not Applicable
- Conditions
- Acute Lymphoblastic Leukemia
- Registration Number
- JPRN-UMIN000003375
- Lead Sponsor
- Tokyo Children's Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
secondary leukemia previously treated patients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5y event free survival 5y overall survival
- Secondary Outcome Measures
Name Time Method The frequency of therapy toxicity